1Mitwally M ,Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate[J]. Fertil Stcril, 2001,75 (2) :305-309.
2Atay V, Cam C, Muhcu M, et al. Comparion of letrozole and clomiphene citrate in women with polycystic Ovaries undergoing stimulation[ J]. J latmed Res ,2006,34( 1 ) :73.
3Shozu M, Sebastian S, Takayama K, et al. Estrogen excess associated with novel gain-of-function mutations affecting the arnmatase gene [J]. N Engl J Med ,2000,348(19):1855-1865.
6Schoolcraft W, Surrey ES, Minjarez D, et al. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol [ J ]. Fertil Steril, 2008,89( 1 ) :151-156.
7Garcia-Velasco JA. Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized placebo-controlled trial [ J ]. Fertil Stefil, 2008,8 ( 1 ) : 16.
8Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients : a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryocryopreservation[J]. J Clin Oncol, 2005,23( 19): 4347-4353.
9Mitwally MF, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation[ J]. Am J Obstet Gynecol, 2005,192(2) :381-386.
